Tilray Brands Inc (TLRY) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock benefits from positive regulatory developments, improving financial metrics like gross margin, and favorable options sentiment. Despite some negative financial trends, the long-term growth potential in the cannabis industry and recent regulatory changes make this a compelling investment opportunity.
The MACD is positive and contracting, indicating a potential bullish trend. RSI is neutral at 48.875, and moving averages are converging, suggesting no strong directional trend. Key support is at 6.417, and resistance is at 7.555, with the stock trading near its support level, offering a potential entry point.

U.S. government reclassification of state-licensed medical marijuana to Schedule III, reducing regulatory hurdles and offering tax relief.
Improved gross margin by 55.35% YoY in Q3
Analysts upgrading the stock and citing potential regulatory changes as a growth driver.
Decline in net income (-96.63% YoY) and EPS (-97.24% YoY) in Q3
Uncertainty over hemp restrictions and higher aluminum costs impacting the beverage business.
Revenue increased by 11.28% YoY to $206.73 million in Q3 2026. Gross margin improved significantly to 24.11%, up 55.35% YoY. However, net income dropped to -$26.57 million, and EPS declined to -$0.24, reflecting challenges in profitability.
Analysts are mixed but leaning positive. Roth Capital upgraded the stock to Buy with a $10 price target, citing steady Canadian business and improving international operations. However, Canaccord and Alliance Global lowered their price targets, citing challenges in the beverage segment and regulatory uncertainty.